Skip to main content

Table 4 Significant Gene Ontology (GO) biological processes in CD8+ T cells of polymyositis and dermatomyositis patients

From: T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients

GO biological process complete

Fold enrichment

p value

FDR

Lymphocyte migration (GO:0072676)

11.50

1.05E-04

4.19E-02

Regulation of T-cell differentiation (GO:0045580)

10.10

4.82E-07

2.50E-03

Regulation of lymphocyte differentiation (GO:0045619)

8.31

2.24E-06

3.88E-03

Myeloid leukocyte migration (GO:0097529)

8.17

1.26E-04

4.69E-02

Response to transforming growth factor beta (GO:0071559)

6.73

1.11E-04

4.31E-02

Regulation of leukocyte differentiation (GO:1902105)

5.48

2.05E-05

1.68E-02

Regulation of T cell activation (GO:0050863)

5.26

4.48E-06

6.34E-03

Leukocyte migration (GO:0050900)

5.04

2.79E-06

4.35E-03

Positive regulation of GTPase activity (GO:0043547)

4.42

1.10E-05

1.15E-02

Positive regulation of cell adhesion (GO:0045785)

4.26

3.41E-05

2.41E-02

Positive regulation of MAPK cascade (GO:0043410)

3.85

1.11E-05

1.08E-02

Regulation of GTPase activity (GO:0043087)

3.75

5.71E-05

3.18E-02

Regulation of cell activation (GO:0050865)

3.54

2.88E-05

2.24E-02

Regulation of leukocyte activation (GO:0002694)

3.51

5.87E-05

3.05E-02

Transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)

3.47

1.21E-04

4.61E-02

Regulation of MAPK cascade (GO:0043408)

3.42

6.96E-06

8.34E-03

Regulation of cell adhesion (GO:0030155)

3.27

6.93E-05

3.27E-02

Enzyme linked receptor protein signaling pathway (GO:0007167)

3.08

7.94E-05

3.53E-02

Cell migration (GO:0016477)

2.91

3.48E-05

2.35E-02

Positive regulation of immune system process (GO:0002684)

2.88

9.42E-06

1.05E-02

Regulation of immune system process (GO:0002682)

2.75

2.77E-07

2.16E-03

Positive regulation of intracellular signal transduction (GO:1902533)

2.75

4.75E-05

2.84E-02

Regulation of immune response (GO:0050776)

2.70

3.87E-05

2.51E-02

Positive regulation of catalytic activity (GO:0043085)

2.45

3.19E-05

2.36E-02

Immune response (GO:0006955)

2.41

5.32E-06

6.91E-03

Cell surface receptor signaling pathway (GO:0007166)

2.31

5.02E-07

1.95E-03

Positive regulation of signal transduction (GO:0009967)

2.31

6.66E-05

3.24E-02

Positive regulation of molecular function (GO:0044093)

2.24

7.60E-05

3.48E-02

Regulation of intracellular signal transduction (GO:1902531)

2.22

3.92E-05

2.44E-02

Immune system process (GO:0002376)

2.21

8.12E-07

2.11E-03

Regulation of multicellular organismal development (GO:2000026)

2.15

8.34E-05

3.61E-02

Positive regulation of response to stimulus (GO:0048584)

2.14

1.65E-05

1.51E-02

Regulation of catalytic activity (GO:0050790)

2.12

1.83E-05

1.59E-02

Regulation of signal transduction (GO:0009966)

2.01

2.08E-06

4.05E-03

Regulation of developmental process (GO:0050793)

2.00

5.79E-05

3.11E-02

Regulation of signaling (GO:0023051)

2.00

5.40E-07

1.68E-03

Regulation of cell communication (GO:0010646)

1.99

8.44E-07

1.88E-03

Regulation of response to stimulus (GO:0048583)

1.91

2.14E-07

3.33E-03

Regulation of multicellular organismal process (GO:0051239)

1.91

6.12E-05

3.08E-02

Regulation of molecular function (GO:0065009)

1.84

8.55E-05

3.60E-02

Signaling (GO:0023052)

1.58

5.65E-05

3.26E-02

Cell communication (GO:0007154)

1.55

9.36E-05

3.84E-02

  1. GO Gene ontology
  2. Significant GO biological processes for the differentially expressed genes in CD8+ T cells of patients with dermatomyositis and patients with polymyositis. Fisher’s exact test with false discovery rate correction (< 0.05) was used to determine significant biological processes. The genes mapped to each GO can be found in Additional file 5: Table S10